About The Study: The results of this study suggest that the majority of fish oil supplement labels make health claims, usually in the form of structure/function claims, that imply a health benefit across a variety of organ systems despite a lack of trial data showing efficacy. Significant heterogeneity exists in the daily dose of eicosapentaenoic acid + docosahexaenoic acid in available supplements, leading to potential variability in safety and efficacy between supplements.
Authors: Ann Marie Navar, M.D., Ph.D., of the University of Texas Southwestern Medical Center in Dallas, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2023.2424)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2023.2424?guestAccessKey=c0dd75d6-3fe6-46c4-bab7-44ed4535af9c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082323
Journal
JAMA Cardiology